SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-006248
Filing Date
2017-04-28
Accepted
2017-04-28 15:04:22
Documents
1
Period of Report
2017-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3021
  Complete submission text file 0001179110-17-006248.txt   4549
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCONOVA THERAPEUTICS 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
MARINO JAMES J (Reporting) CIK: 0001198578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 17794703